½ÃÀ庸°í¼­
»óǰÄÚµå
1551621

¼¼°èÀÇ Á¤¸Æ ³» ÀýÁ¦ ÀåÄ¡ ½ÃÀå

Endovenous Ablation Devices

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Á¤¸Æ ³» ÀýÁ¦ ÀåÄ¡ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 6¾ï 9,360¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 5¾ï 2,060¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â Á¤¸Æ ³» ÀýÁ¦ ÀåÄ¡ ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 6¾ï 9,360¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â µ¿¾È 4.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Á¤¸Æ ³» ·¹ÀÌÀú ÀýÁ¦¼ú(EVLT) ÀåÄ¡´Â 4.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 4¾ï 8,600¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. RFA(Radiofrequency Ablation Therapy) ±â±â ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È 4.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 1¾ï 4,180¸¸ ´Þ·¯, Áß±¹Àº CAGR 7.9%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ Á¤¸Æ ÀýÁ¦ ÀåÄ¡ ½ÃÀåÀº 2023³â 1¾ï 4,180¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2023-2030³â 7.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2030³â±îÁö 1¾ï 4,880¸¸ ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ºÐ¼® ±â°£ µ¿¾È °¢°¢ 1.4%¿Í 3.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ 2.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è Á¤¸Æ ÀýÁ¦¼ú ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

Á¤¸Æ ³» ÀýÁ¦ ÀåÄ¡´Â ÇÏÁöÁ¤¸Æ·ù Ä¡·á¸¦ ¾î¶»°Ô º¯È­½Ãų ¼ö ÀÖÀ»±î?

Á¤¸Æ ³» ÀýÁ¦ ÀåÄ¡´Â Á¤¸Æ·ù Ä¡·á¿¡ Çõ¸íÀ» °¡Á®¿ÔÀ¸¸ç, Á¤¸Æ ¹Ú¸®¼ú°ú °°Àº ÀüÅëÀûÀÎ ¼ö¼úÀû ¹æ¹ý¿¡ ´ëÇÑ ÃÖ¼Ò Ä§½ÀÀû Ä¡·á¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÇÏÁöÁ¤¸Æ·ù´Â Á¾Á¾ ´Ù¸®¿¡ ³ªÅ¸³ª´Â ºÎÇ®¾î ¿À¸£°í µÚƲ¸° Á¤¸ÆÀÌ Æ¯Â¡À̸ç, Ç÷¾×ÀÌ °íÀÌ´Â Á¤¸Æ ³» °áÇÔ ÀÖ´Â ÆÇ¸·À¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÀÌ »óŸ¦ ¹æÄ¡ÇÏ¸é ºÒÆíÇÔ°ú ÅëÁõ, ±×¸®°í ´õ ½É°¢ÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¤¸Æ ³» ¼ÒÀÛ¼úÀº ¿­ ¿¡³ÊÁö ¶Ç´Â È­ÇÐ ¿¡³ÊÁö¸¦ Á÷Á¢ Á¤¸Æ¿¡ Á¶»çÇÏ¿© Á¤¸ÆÀ» ºØ±«½ÃŰ°í Æó¼â½ÃŰ´Â ¹æ¹ýÀÔ´Ï´Ù. ½Ã°£ÀÌ Áö³²¿¡ µû¶ó Ä¡·áµÈ Á¤¸ÆÀº ü³»¿¡ Èí¼öµÇ°í Ç÷·ù´Â ÀÚ¿¬½º·´°Ô °Ç°­ÇÑ Á¤¸ÆÀ¸·Î ¹æÇâÀ» ÀüȯÇÕ´Ï´Ù. ÀÌ ¼ö¼úÀº ÀϹÝÀûÀ¸·Î ±¹¼Ò ¸¶Ãë·Î ½ÃÇàµÇ¸ç, ±âÁ¸ ¼ö¼ú¿¡ ºñÇØ ȸº¹ ½Ã°£ ´ÜÃà, ÅëÁõ °¨¼Ò, ÈäÅÍ °¨¼Ò µî ¿©·¯ °¡Áö ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. Á¤¸Æ ³» ¼ÒÀÛ¼úÀº Á¤¸Æ·ùÀÇ Àå±âÀûÀÎ °³¼± È¿°ú¸¦ ¹Ý¿µÇÏ¿© ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ÁöÁö¸¦ ¹Þ°í ÀÖÀ¸¸ç, Àü ¼¼°è ¸¹Àº Áö¿ª¿¡¼­ Ç¥ÁØ Ä¡·á¹ýÀ¸·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

Á¤¸Æ ³» ÀýÁ¦¼ú Àåºñ´Â ¾î¶² ±â¼ú Çõ½ÅÀ¸·Î °³¼±µÇ°í Àִ°¡?

±â¼ú Çõ½ÅÀº Á¤¸Æ ³» ÀýÁ¦ ÀåºñÀÇ ¾ÈÀü¼º, È¿°ú ¹× Á¤È®¼ºÀ» Áö¼ÓÀûÀ¸·Î °³¼±ÇÏ¿© Àû¿ë ¹üÀ§¸¦ ³ÐÈ÷°í ȯÀÚ °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. RFA(Radiofrequency Ablation Therapy, RFA)¿Í EVLT(Endovenous Laser Therapy, EVLT)´Â ÀÌ·¯ÇÑ Àåºñ¿¡ »ç¿ëµÇ´Â µÎ °¡Áö ÁÖ¿ä ±â¼ú·Î, °¢°¢ °íÀ¯ÇÑ ÀåÁ¡À» °¡Áö°í ÀÖ½À´Ï´Ù. È¿°ú¸¦ ¾ò´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÇ ÃÖ±Ù µ¿Çâ¿¡´Â º¸´Ù ÀÛ°í »ç¿ëÇϱ⠽¬¿ì¸ç Á¦¾î ±â´ÉÀÌ °­È­µÈ ÀåºñÀÇ °³¹ßÀÌ Æ÷ÇÔµÇ¾î ½Ã¼ú Áß ´õ ³ôÀº Á¤È®µµ¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, RFAÀÇ °æ¿ì Ŭ·ÎÀú ÆÐ½ºÆ® Ä«Å×ÅÍ, EVLTÀÇ °æ¿ì ¹æ»çÇü ¼¶À¯ Ä«Å×ÅÍ¿Í °°Àº Ä«Å×ÅÍ ¼³°èÀÇ Çõ½ÅÀº Á¤¸Æ ³» ¿¡³ÊÁö ºÐÆ÷¸¦ °³¼±ÇÏ¿© º¸´Ù ¾ÈÁ¤ÀûÀÎ °á°ú¿Í ÇÕº´Áõ À§Çè °¨¼Ò·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¹ßÀüÀº ¿­À̳ª ´Ù·®ÀÇ ¸¶ÃëÁ¦°¡ ÇÊ¿ä ¾ø´Â ºñ¿­ ¹× ºñºÐ»ç ¹æ½ÄÀÇ ÀýÁ¦¹ý(MOCA)À̳ª ½Ã¾Æ³ë¾ÆÅ©¸±·¹ÀÌÆ® Á¢ÂøÁ¦¸¦ ÀÌ¿ëÇÑ Æó»ö°ú °°Àº ºñ¿­ ¹× ºñºÐ»ç ¹æ½ÄÀÇ µîÀåÀ¸·Î ȯÀÚÀÇ ºÒÆíÇÔ°ú ȸº¹ ½Ã°£À» ´õ¿í ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÇ ¹ßÀüÀ¸·Î Á¤¸Æ ³» ¼ÒÀÛ¼úÀº ´õ¿í Ä£¼÷Çϰí È¿°úÀûÀÎ Ä¡·á¹ýÀÌ µÇ¾î ´õ ¸¹Àº ȯÀÚµéÀÇ ¿ä±¸¿¡ ºÎÀÀÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

ȯÀÚÀÇ ¼±È£µµ ¹× °Ç°­ °ü¸® µ¿ÇâÀº Á¤¸Æ ÀýÁ¦ ÀåÄ¡ »ç¿ë¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?

ȯÀÚÀÇ ¼±È£µµ¿Í °Ç°­ °ü¸® Æ®·»µå´Â Á¤¸Æ ³» ÀýÁ¦ ÀåÄ¡ äÅÿ¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀÌ ´ú ħ½ÀÀûÀÌ°í ´Ù¿îŸÀÓÀÌ ÀûÀº Ä¡·á¸¦ ¿øÇϸ鼭 Á¤¸Æ ³» ¼ÒÀÛ¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ¿Ü·¡ ¼ö¼ú Áõ°¡¿Í ÃÖ¼Ò ºñ¿ëÀ¸·Î ÃÖ»óÀÇ °á°ú¸¦ ¾ò´Â µ¥ ÁßÁ¡À» µÐ °¡Ä¡ ±â¹Ý Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø °Íµµ ÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¤¸Æ ³» ¼ÒÀÛ¼úÀÇ ÆíÀǼºÀº ÀÌ·¯ÇÑ Ãß¼¼¿Í Àß ¸Â¾Æ¶³¾îÁö´Âµ¥, ȯÀÚ°¡ ÇÏ·ç ¸¸¿¡ ÀÏ»ó »ýȰ·Î º¹±ÍÇÒ ¼ö ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ, Å« ÈäÅͰ¡ ³²Áö ¾Ê°í Àç¹ß À§ÇèÀÌ ³·´Ù´Â ÀåÁ¡À¸·Î ÀÎÇØ ¹Ì¿ëÀûÀÎ Ãø¸éÀ» Áß½ÃÇϴ ȯÀڵ鿡°Ôµµ Àαâ ÀÖ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ¸¸¼ºÀûÀÎ Á¤¸ÆÁúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡´Â Á¤¸Æ ³» ¼ÒÀÛ¼ú°ú °°Àº È¿°úÀûÀÌ°í Æí¸®ÇÑ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÌ È¯ÀÚ Áß½ÉÀÇ Ä¡·á¸¦ Á¡Á¡ ´õ ¿ì¼±½ÃÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÀåºñÀÇ Àαâ¿Í »ç¿ëÀº °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤¸Æ ÀýÁ¦ ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

Á¤¸Æ ÀýÁ¦ ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ȯÀÚÃþÀÇ º¯È­, ÀÇ·á °üÇàÀÇ ÁøÈ­¿Í ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ °í·ÉÈ­, ºñ¸¸, Àå½Ã°£ ¼­¼­ ÀÏÇÏ´Â µî À§Çè ¿äÀÎÀ» °¡Áø »ç¶÷µé »çÀÌ¿¡¼­ Á¤¸Æ·ù À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¸´Ù È¿À²ÀûÀÌ°í ¾ÈÀüÇÑ ÀýÁ¦ ÀåºñÀÇ °³¹ß°ú °°Àº ±â¼úÀû ¹ßÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Ä¡·áÀÇ ¹üÀ§°¡ È®´ëµÇ¾î ´õ ¸¹Àº ȯÀÚ±ºÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, Àúħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¶±â ȸº¹°ú ¹Ì¿ëÀû °á°úÀÇ °³¼±¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °Íµµ Å« ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Ü·¡ Áø·á·ÎÀÇ Àüȯ°ú ºñ¿ë È¿À²¼º°ú ȯÀÚ ¸¸Á·µµ¸¦ Áß½ÃÇÏ´Â °¡Ä¡ ±â¹Ý ÀÇ·á ¸ðµ¨ Ã¤ÅÃÀÌ Áõ°¡Çϸ鼭 Á¤¸Æ ³» ÀýÁ¦¼ú Àåºñ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ ÀÇ·á ÀÎÇÁ¶ó°¡ Àü ¼¼°èÀûÀ¸·Î È®´ëµÇ¸é¼­ ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ¾î ½ÃÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº Àåºñ ±â¼ú ¹× ½Ã¼úÀÇ Áö¼ÓÀûÀÎ Çõ½Å°ú ÇÔ²² Á¤¸Æ ÀýÁ¦¼ú ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 51°Ç)

  • Alfresa Pharma Corporation
  • AngioDynamics Inc.
  • AtriCure Inc.
  • biolitec£¨R£©Holding GmbH & Co KG
  • Canyon Medical Inc.
  • Eufoton srl
  • F Care Systems
  • LSO Medical
  • Merit Medical Systems Inc.
  • Olympus Europa SE & Co.
  • Quanta System S.p.A
  • Smith & Nephew plc
  • Teleflex Incorporated
  • Total Vein Systems
  • Venclose Inc.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • È£ÁÖ
  • Àεµ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • À̶õ
  • À̽º¶ó¿¤
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦4Àå °æÀï

LSH 24.09.20

Global Endovenous Ablation Devices Market to Reach US$693.6 Million by 2030

The global market for Endovenous Ablation Devices estimated at US$520.6 Million in the year 2023, is expected to reach US$693.6 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Endovenous Laser Ablation Therapy (EVLT) Devices, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$486.0 Million by the end of the analysis period. Growth in the Radiofrequency Ablation (RFA) Devices segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$141.8 Million While China is Forecast to Grow at 7.9% CAGR

The Endovenous Ablation Devices market in the U.S. is estimated at US$141.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$148.8 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Endovenous Ablation Devices Market - Key Trends and Drivers Summarized

How Do Endovenous Ablation Devices Transform the Treatment of Varicose Veins?

Endovenous ablation devices have revolutionized the treatment of varicose veins, offering a minimally invasive alternative to traditional surgical methods like vein stripping. Varicose veins, characterized by swollen, twisted veins that often appear on the legs, result from faulty valves within the veins that cause blood to pool. This condition can lead to discomfort, pain, and more severe complications if left untreated. Endovenous ablation works by delivering thermal or chemical energy directly into the affected vein, causing it to collapse and seal shut. Over time, the treated vein is absorbed by the body, and blood flow is naturally redirected to healthier veins. This procedure, typically performed under local anesthesia, offers numerous advantages, including shorter recovery times, reduced pain, and minimal scarring compared to traditional surgery. The growing preference for endovenous ablation among both patients and healthcare providers reflects its effectiveness in providing long-term relief from varicose veins, making it the standard of care in many parts of the world.

What Technological Innovations Are Enhancing Endovenous Ablation Devices?

Technological innovations are continually enhancing the safety, efficacy, and precision of endovenous ablation devices, broadening their application and improving patient outcomes. Radiofrequency ablation (RFA) and endovenous laser therapy (EVLT) are the two primary technologies used in these devices, each offering unique benefits. RFA uses radiofrequency energy to heat the vein wall, causing it to collapse, while EVLT employs laser energy to achieve the same result. Recent advancements in these technologies include the development of more compact, user-friendly devices with enhanced control features, allowing for greater precision during the procedure. Furthermore, innovations in catheter design, such as the introduction of closure fast catheters in RFA and radial fiber catheters in EVLT, have improved energy distribution within the vein, leading to more consistent results and reduced risk of complications. Another significant development is the advent of non-thermal, non-tumescent ablation methods, such as mechanochemical ablation (MOCA) and cyanoacrylate glue occlusion, which eliminate the need for heat and large volumes of anesthetic, further minimizing patient discomfort and recovery time. These technological advancements are making endovenous ablation procedures more accessible and effective, catering to a broader range of patient needs.

How Are Patient Preferences and Healthcare Trends Influencing the Use of Endovenous Ablation Devices?

Patient preferences and broader healthcare trends are playing a crucial role in shaping the adoption of endovenous ablation devices. As patients increasingly seek treatments that are less invasive and require minimal downtime, the demand for endovenous ablation has surged. This shift is partly driven by the rise in outpatient procedures and the growing emphasis on value-based care, where the focus is on achieving the best possible outcomes at the lowest cost. The convenience of endovenous ablation, which often allows patients to return to normal activities within a day, aligns well with these trends. Additionally, the aesthetic benefits of the procedure, including the absence of large scars and the reduced risk of recurrence, have made it a popular choice among individuals concerned about the cosmetic aspects of varicose veins. The expanding demographic of aging populations, who are more prone to chronic venous insufficiency, further drives the demand for effective and convenient treatments like endovenous ablation. As healthcare providers increasingly prioritize patient-centered care, the popularity and utilization of these devices are expected to continue growing.

What Is Driving Growth in the Endovenous Ablation Devices Market?

The growth in the endovenous ablation devices market is driven by several factors closely linked to technological advancements, changing patient demographics, and evolving healthcare practices. The increasing prevalence of varicose veins, particularly among the aging population and individuals with risk factors such as obesity and prolonged standing, has led to a greater need for effective treatment options. Technological advancements, such as the development of more efficient and safer ablation devices, have expanded the scope of these treatments, making them accessible to a broader patient base. The rising awareness of minimally invasive treatment options and the associated benefits of quicker recovery and improved cosmetic outcomes are also significant drivers. Additionally, the shift towards outpatient procedures and the increasing adoption of value-based healthcare models, which emphasize cost-effectiveness and patient satisfaction, have boosted the demand for endovenous ablation devices. The global expansion of healthcare infrastructure, particularly in emerging markets, is further propelling the market as access to advanced medical technologies improves. These factors, combined with ongoing innovations in device technology and procedural techniques, are fueling the continued growth of the endovenous ablation devices market.

Select Competitors (Total 51 Featured) -

  • Alfresa Pharma Corporation
  • AngioDynamics Inc.
  • AtriCure Inc.
  • biolitec(R) Holding GmbH & Co KG
  • Canyon Medical Inc.
  • Eufoton srl
  • F Care Systems
  • LSO Medical
  • Merit Medical Systems Inc.
  • Olympus Europa SE & Co. KG
  • Quanta System S.p.A
  • Smith & Nephew plc
  • Teleflex Incorporated
  • Total Vein Systems
  • Venclose Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Endovenous Ablation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Venous Insufficiency Expands Addressable Market Opportunity for Endovenous Ablation Devices
    • Advancements in Laser and Radiofrequency Technologies Propel Growth in Minimally Invasive Ablation Procedures
    • Increasing Patient Preference for Outpatient and Ambulatory Care Drives Adoption of Endovenous Ablation Devices
    • Growing Awareness of Varicose Vein Treatments Spurs Demand for Safe and Effective Endovenous Ablation Options
    • Integration of Imaging and Navigation Systems Throws the Spotlight on Precision-Guided Endovenous Ablation
    • Emergence of Hybrid Ablation Techniques Expands Market Scope for Versatile Treatment Modalities
    • Rising Geriatric Population and Associated Venous Disorders Generate Demand for Long-Lasting Ablation Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endovenous Ablation Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endovenous Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Endovenous Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Endovenous Laser Ablation Therapy (EVLT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Endovenous Laser Ablation Therapy (EVLT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Endovenous Laser Ablation Therapy (EVLT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Radiofrequency Ablation (RFA) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Radiofrequency Ablation (RFA) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Radiofrequency Ablation (RFA) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Non-Thermal Non-Tumescent (NTNT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Non-Thermal Non-Tumescent (NTNT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Non-Thermal Non-Tumescent (NTNT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • JAPAN
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • CHINA
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • EUROPE
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Endovenous Ablation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Endovenous Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • FRANCE
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • GERMANY
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Endovenous Ablation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Endovenous Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • INDIA
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Endovenous Ablation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Endovenous Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Endovenous Ablation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Endovenous Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030
  • AFRICA
    • Endovenous Ablation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Endovenous Ablation Devices by Device Type - Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Endovenous Ablation Devices by Device Type - Percentage Breakdown of Value Sales for Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices and Non-Thermal Non-Tumescent (NTNT) Devices for the Years 2014, 2024 & 2030

IV. COMPETITION

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦